• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALUNG TECHNOLOGIES, INC. HEMOLUNG RAS; EXTRACORPOREAL SYSTEM FOR CARBON DIOXIDE REMOVAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALUNG TECHNOLOGIES, INC. HEMOLUNG RAS; EXTRACORPOREAL SYSTEM FOR CARBON DIOXIDE REMOVAL Back to Search Results
Model Number HL-CR4-01-000
Device Problem Device Handling Problem (3265)
Patient Problem Low Blood Pressure/ Hypotension (1914)
Event Date 03/01/2021
Event Type  Injury  
Manufacturer Narrative
Alung technologies, inc.Manufactures the hemolung ras and catheter.The incident occurred in (b)(4), massachusetts.During therapy, a clinical study patient experienced hypotension.Alung was not initially made aware of this event as this was originally reported as not meeting criteria of seriousness and unrelated to use of the device.The device causality was indicated to be probably related as this was probably related to line placement of device.The data log from therapy has been retrieved and reviewed by both clinical and software engineering staff.Consistent blood flows and co2 removal were observed throughout therapy.There were high blood flow alarms intermittently throughout therapy, but rpms were adjusted accordingly.There were no unexpected alarms or critical errors.Therapy was provided as intended.Hemodynamic instability is a known possible occurrence with use of extracorporeal therapy and/or critical illness.Examination of the controller data log shows that therapy was provided as intended.Alung will continue to monitor any issues as they are reported.This mdr is being filed in response to a retrospective view of all alung complaints, which identified that the reporting decision for this complaint was not correct.This mdr is being filed retrospectively to correct the error in the reporting decision.
 
Event Description
Alung technologies, inc.Received a report of a patient experiencing hypotension during hemolung ras therapy.Norepinephrine medication was administered.Hemolung therapy was not discontinued as a result of this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEMOLUNG RAS
Type of Device
EXTRACORPOREAL SYSTEM FOR CARBON DIOXIDE REMOVAL
Manufacturer (Section D)
ALUNG TECHNOLOGIES, INC.
2500 jane st.
suite 1
pittsburgh PA 15203
Manufacturer Contact
ryan coyle
2500 jane st.
suite 1
pittsburgh, PA 15203
MDR Report Key16163820
MDR Text Key307465877
Report Number3009763347-2023-00008
Device Sequence Number1
Product Code QOH
UDI-Device Identifier00850046004346
UDI-Public(01)00850046004346(17)190328
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
DEN210006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 01/13/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/13/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberHL-CR4-01-000
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/13/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/28/2019
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Required Intervention;
-
-